Bausch + Lomb Corporation $BLCO Shares Purchased by Compass Rose Asset Management LP

Compass Rose Asset Management LP increased its holdings in shares of Bausch + Lomb Corporation (NYSE:BLCO) by 22.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,000,000 shares of the company’s stock after buying an additional 180,000 shares during the quarter. Bausch + Lomb accounts for about 2.5% of Compass Rose Asset Management LP’s portfolio, making the stock its 9th largest position. Compass Rose Asset Management LP owned approximately 0.28% of Bausch + Lomb worth $15,070,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. boosted its holdings in Bausch + Lomb by 729.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,322 shares of the company’s stock worth $30,000 after acquiring an additional 2,042 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Bausch + Lomb by 55.3% during the third quarter. Jones Financial Companies Lllp now owns 9,112 shares of the company’s stock valued at $132,000 after acquiring an additional 3,246 shares in the last quarter. Mission Wealth Management LP purchased a new position in shares of Bausch + Lomb in the 3rd quarter valued at approximately $210,000. JPMorgan Chase & Co. purchased a new position in shares of Bausch + Lomb in the 2nd quarter valued at approximately $200,000. Finally, Handelsbanken Fonder AB acquired a new stake in Bausch + Lomb in the 2nd quarter worth approximately $202,000. 11.07% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CFO Sam Eldessouky acquired 4,000 shares of the firm’s stock in a transaction dated Friday, March 6th. The stock was acquired at an average price of $17.13 per share, with a total value of $68,520.00. Following the acquisition, the chief financial officer directly owned 403,130 shares in the company, valued at $6,905,616.90. This represents a 1.00% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP A Robert D. Bailey bought 14,600 shares of the stock in a transaction dated Friday, March 6th. The stock was bought at an average price of $17.15 per share, for a total transaction of $250,390.00. Following the purchase, the executive vice president directly owned 231,890 shares of the company’s stock, valued at approximately $3,976,913.50. The trade was a 6.72% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders have purchased 33,300 shares of company stock valued at $570,868. Company insiders own 0.76% of the company’s stock.

Analyst Ratings Changes

BLCO has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Bausch + Lomb in a research note on Wednesday, January 21st. Wells Fargo & Company lifted their price objective on shares of Bausch + Lomb from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 19th. Citigroup boosted their price objective on shares of Bausch + Lomb from $20.00 to $21.00 and gave the company a “buy” rating in a report on Thursday, February 19th. Evercore set a $18.00 target price on Bausch + Lomb and gave the company an “in-line” rating in a research report on Monday, January 5th. Finally, Wall Street Zen cut Bausch + Lomb from a “buy” rating to a “hold” rating in a research report on Saturday, February 21st. Four investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $18.25.

Bausch + Lomb Stock Performance

BLCO opened at $16.21 on Friday. The firm has a 50 day moving average of $17.27 and a two-hundred day moving average of $16.22. The firm has a market capitalization of $5.76 billion, a PE ratio of -15.89, a P/E/G ratio of 0.68 and a beta of 0.58. The company has a current ratio of 1.55, a quick ratio of 1.04 and a debt-to-equity ratio of 0.77. Bausch + Lomb Corporation has a 12-month low of $10.45 and a 12-month high of $18.92.

Bausch + Lomb (NYSE:BLCO) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). Bausch + Lomb had a positive return on equity of 2.77% and a negative net margin of 7.06%.The business had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.38 billion. During the same quarter in the previous year, the company earned $0.25 EPS. The firm’s revenue was up 9.8% compared to the same quarter last year. On average, analysts anticipate that Bausch + Lomb Corporation will post 0.74 EPS for the current year.

Bausch + Lomb Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.